Siegel C - Search Results

1

IBS patients' willingness to take risks with medications.

Lacy BE, Everhart KK, Weiser KT, DeLee R, Strobel S, Siegel C, Crowell MD. Lacy BE, et al. Among authors: siegel c. Am J Gastroenterol. 2012 Jun;107(6):804-9. doi: 10.1038/ajg.2011.485. Am J Gastroenterol. 2012. PMID: 22664841

2

Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease.

Siegel CA, Allen JI, Melmed GY. Siegel CA, et al. Clin Gastroenterol Hepatol. 2013 Aug;11(8):908-12. doi: 10.1016/j.cgh.2013.05.027. Epub 2013 Jun 5. Clin Gastroenterol Hepatol. 2013. PMID: 23747710 Review.

3

Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Dulai PS, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA. Dulai PS, et al. Among authors: siegel ca. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1443-51; quiz e88-9. doi: 10.1016/j.cgh.2014.01.021. Epub 2014 Jan 22. Clin Gastroenterol Hepatol. 2014. PMID: 24462626 Review.

4

Beware of the swinging pendulum: anti-tumor necrosis factor monotherapy vs combination therapy for inflammatory bowel disease.

Bressler B, Siegel CA. Bressler B, et al. Gastroenterology. 2014 Apr;146(4):884-7. doi: 10.1053/j.gastro.2014.02.018. Epub 2014 Feb 25. Gastroenterology. 2014. PMID: 24576727 No abstract available.

5

Medical marijuana for digestive disorders: high time to prescribe?

Gerich ME, Isfort RW, Brimhall B, Siegel CA. Gerich ME, et al. Am J Gastroenterol. 2015 Feb;110(2):208-14. doi: 10.1038/ajg.2014.245. Epub 2014 Sep 9. Am J Gastroenterol. 2015. PMID: 25199471 Review.

6

Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis.

Stein BN, Pellish RS, Thompson KD, Baptista V, Siegel CA. Stein BN, et al. J Clin Gastroenterol. 2016 Jan;50(1):66-8. doi: 10.1097/MCG.0000000000000370. J Clin Gastroenterol. 2016. PMID: 26191643

7

Is the Hype of Medical Marijuana All Smoke and Mirrors?

Koliani-Pace J, Siegel CA. Koliani-Pace J, et al. Am J Gastroenterol. 2016 Feb;111(2):161-2. doi: 10.1038/ajg.2016.4. Epub 2016 Feb 9. Am J Gastroenterol. 2016. PMID: 26856747

8

Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.

Thompson KD, Connor SJ, Walls DM, Gollins J, Stewart SK, Bewtra M, Baumblatt GL, Holubar SD, Greenup AJ, Sechi A, Girgis A, Rubin DT, Siegel CA. Thompson KD, et al. Inflamm Bowel Dis. 2016 Apr;22(4):940-7. doi: 10.1097/MIB.0000000000000740. Inflamm Bowel Dis. 2016. PMID: 26950308

9

The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.

Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. Dulai PS, et al. Am J Gastroenterol. 2016 Aug;111(8):1147-55. doi: 10.1038/ajg.2016.236. Epub 2016 Jun 14. Am J Gastroenterol. 2016. PMID: 27296941

10

Fostering Collaboration Through Creation of an IBD Learning Health System.

Johnson LC, Melmed GY, Nelson EC, Holthoff MM, Weaver SA, Morgan TS, Siegel CA. Johnson LC, et al. Among authors: siegel ca. Am J Gastroenterol. 2017 Mar;112(3):406-408. doi: 10.1038/ajg.2017.9. Epub 2017 Feb 14. Am J Gastroenterol. 2017. PMID: 28195179 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

874 results

Search Page

Filters